TrialAesthetic surgery journal2022

Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study.

Daniel S Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.